Davimet With Fluoride (Pedi Mv No.247/Fluoride) Patent Expiration, LOE Window & CMS Spending

Davimet With Fluoride (Pedi Mv No.247/Fluoride) by Puretek Corpora: Off-Patent Genericized (AB Competition), 0 AB generics, $186K 2024 CMS Part D & Medicaid spend, and 1 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorPuretek Corpora
FDA Application & PathwayReconciled (UNLINKED)
Exclusivity / Cliff HorizonOff-Patent Genericized (AB Competition)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity DateNot listed / N/A
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors0
2024 CMS Total Public Spend$186K
2024 Medicare Part D Spend$0
2024 Medicaid Spend$186K
Reported Wholesale Price Change (CA SB 17)1 WAC filings (max 136.3% 2-yr change)